v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities    
Net income $ 77 $ 37
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and Amortization expense 211 218
Stock-based compensation expense 25 28
Deferred income taxes 16 (9)
(Gain) loss on divestiture and disposal of assets, net (30) 5
Bargain purchase gain from acquisition 0 (5)
Loss (earnings) from equity investments 2 2
Changes in assets and liabilities:    
Receivables 29 80
Inventories (108) (77)
Current payables and accrued expenses (42) 77
Contract liabilities 22 (16)
Employee benefit plans (34) (23)
Settlement assets and liabilities, net (14) 45
Other assets and liabilities (29) (98)
Net cash provided by operating activities 125 264
Investing activities    
Capital expenditures (80) (69)
Additions to capitalized software (39) (26)
Business acquisitions, net of cash acquired (17) 0
Purchase of intellectual property 0 (13)
Proceeds from sale of property, plant and equipment 36 0
Proceeds from divestiture 11 0
Sale (purchase) of investments, net 1 (1)
Other investing activities, net 0 (1)
Net cash used in investing activities (88) (110)
Financing activities    
Borrowings on term credit facilities 11 0
Payments on term credit facilities (90) (55)
Borrowings on revolving credit facilities 750 919
Payments on revolving credit facilities (750) (894)
Payments on other financing arrangements (2) (2)
Proceeds from employee stock plans 7 3
Tax withholding payments on behalf of employees (8) (14)
Payments on acquisition holdback (16) (5)
Principal payments for finance lease obligations (3) (1)
Other financing activities (1) 0
Net cash used in financing activities (102) (49)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 11 (7)
Increase (decrease) in cash, cash equivalents, and restricted cash (54) 98
Cash, cash equivalents, and restricted cash at beginning of period 641 586
Cash, cash equivalents, and restricted cash at end of period $ 587 $ 684

Source

10-Q XBRL Zip